
浏览全部资源
扫码关注微信
1.新疆医科大学第一附属医院药学部,乌鲁木齐 830011
2.新疆药物临床研究重点实验室,乌鲁木齐 830011
3.新疆医科大学药学院,乌鲁木齐 830017
4.新疆黑果枸杞生物科技有限公司,新疆 库尔勒 841009
副教授,副主任药师,博士。研究方向:新疆特色药用植物开发与应用。E-mail:1532527694@qq.com
教授,博士生导师,博士。研究方向:天然产物研究与开发。E-mail:hjp_yft@163.com
收稿:2025-08-19,
修回:2025-11-25,
录用:2025-12-09,
纸质出版:2026-01-15
移动端阅览
谯明,赵耀,朱毅,等.黑果枸杞改善睡眠的作用及机制研究 [J].中国药房,2026,37(01):24-29.
QIAO Ming,ZHAO Yao,ZHU Yi,et al.Study on the effects and mechanisms of Lycium ruthenicum Murr. in improving sleep[J].ZHONGGUO YAOFANG,2026,37(01):24-29.
谯明,赵耀,朱毅,等.黑果枸杞改善睡眠的作用及机制研究 [J].中国药房,2026,37(01):24-29. DOI: 10.6039/j.issn.1001-0408.2026.01.05.
QIAO Ming,ZHAO Yao,ZHU Yi,et al.Study on the effects and mechanisms of Lycium ruthenicum Murr. in improving sleep[J].ZHONGGUO YAOFANG,2026,37(01):24-29. DOI: 10.6039/j.issn.1001-0408.2026.01.05.
目的
2
探究黑果枸杞改善睡眠的作用及机制。
方法
2
借助网络药理学挖掘黑果枸杞改善睡眠的活性成分及对应疾病靶点,并进行富集分析。以咖啡因诱导斑马鱼构建睡眠剥夺模型,分别给予0.1、0.2、0.4 mg/mL黑果枸杞提取物(LRME)干预24 h后,观察斑马鱼行为学变化和脑部神经元病理学变化,检测斑马鱼体内炎症因子[白细胞介素6(IL-6)、IL-1β、IL-10、肿瘤坏死因子α(TNF-α)
]
、氧化应激指标[超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)
]
和神经递质[5-羟色胺(5-HT)、
γ
-氨基丁酸(GABA)、谷氨酸(Glu)、多巴胺(DA)和去甲肾上腺素(NE)
]
水平,并检测斑马鱼体内蛋白激酶B1(AKT1)、磷酸化AKT1(p-AKT1)、表皮生长因子受体(EGFR)、B细胞淋巴瘤2(Bcl-2)、肉瘤原癌基因编码的非受体酪氨酸激酶(SRC)、热休克蛋白90α家族A类成员1(HSP90AA1)蛋白表达水平。
结果
2
通过网络药理学挖掘共得到12个活性成分及176个疾病交集靶点,其中芹菜素、柚皮素等为核心活性成分,AKT1、EGFR等为核心靶点,EGFR酪氨酸激酶抑制剂耐药信号通路为关键通路。LRME低、中、高剂量组斑马鱼的睡眠改善率分别为54.60%、69.03%、77.97%,运动距离抑制比分别为0.57、0.83、0.95。与模型组比较,LRME中、高剂量组斑马鱼的静息次数、静息时间和静息距离均显著增加/延长(
P
<0.05);脑部神经元损伤减轻;体内IL-6、IL-1β、TNF-α、MDA、Glu、DA、NE水平和AKT1、p-AKT1、EGFR、SRC、HSP90AA1蛋白表达水平均显著降低(
P
<0.05),IL-10、SOD、GSH-Px、CAT、5-HT、GABA水平和Bcl-2蛋白表达水平均显著升高(
P
<0.05)。
结论
2
黑果枸杞具有改善睡眠的作用,其机制可能与调节炎症反应、氧化应激、神经递质平衡以及EGFR酪氨酸激酶抑制剂耐药信号通路有关。
OBJECTIVE
2
To investigate the effects and mechanisms of
Lycium ruthenicum
Murr. in improving sleep.
METHODS
2
Network pharmacology was employed to identify the active components of
L. ruthenicum
and their associated disease targets, followed by enrichment analysis. A caffeine‑induced zebrafish model of sleep deprivation was established, and the zebrafish were treated with
L. ruthenicum
Murr. extract (LRME) at concentrations of 0.1, 0.2 and 0.4 mg/mL, respectively; 24 h later, behavioral changes of zebrafish and pathological alterations in brain neurons were subsequently observed. The levels of inflammatory factors [interleukin-6 (IL-6), IL-1β, IL-10, tumor necrosis factor-α (TNF-α)
]
, oxidative stress markers [superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), catalase (CAT)
]
, a
nd neurotransmitters [5-hydroxytryptamine (5-HT),
γ
-aminobutyric acid (GABA), glutamic acid (Glu), dopamine (DA), and norepinephrine (NE)
]
were measured. The protein expression levels of protein kinase B1 (AKT1), phosphorylated AKT1 (p-AKT1), epidermal growth factor receptor (EGFR), B-cell lymphoma 2 (Bcl-2), sarcoma proto-oncogene,non-receptor tyrosine kinase (SRC), and heat shock protein 90α family class A member 1 (HSP90AA1) in the zebrafish were also determined.
RESULTS
2
A total of 12 active components and 176 intersecting disease targets were identified through network pharmacology analysis. Among these, apigenin, naringenin and others were recognized as core active compounds, while AKT1, EGFR and others served as key targets; EGFR tyrosine kinase inhibitor resistance signaling pathway was identified as the critical pathway. The sleep improvement rates in zebrafish of LRME low-, medium-, and high-dose groups were 54.60%, 69.03% and 77.97%, respectively, while the inhibition ratios of locomotor distance were 0.57, 0.83 and 0.95, respectively. Compared with the model group, the number of resting counts, resting time and resting distance were significantly increased/extended in LRME medium- and high-dose groups (
P
<0.05). Neuronal damage in the brain was alleviated. Additionally, the levels of IL-6, IL-1β, TNF-α, MDA, Glu, DA and NE, as well as the protein expression levels of AKT1, p-AKT1, EGFR, SRC and HSP90AA1, were markedly reduced (
P
<0.05), while the levels of IL-10, SOD, GSH-Px, CAT, 5-HT and GABA, as well as Bcl-2 protein expression, were significantly elevated (
P
<0.05).
CONCLUSIONS
2
L. ruthenicum
Murr. demonstrates sleep-improving effects, and its specific mechanism may be related to the regulation of inflammatory responses, oxidative stress, neurotransmitter balance, and the EGFR tyrosine kinase inhibitor resistance signaling pathway.
RIEMANN D , DRESSLE R J , BENZ F , et al . Chronic insomnia,REM sleep instability and emotional dysregulation:a pathway to anxiety and depression? [J ] . J Sleep Res , 2025 , 34 ( 2 ): e14252 .
ZOLFAGHARI S , KEIL A , PELLETIER A , et al . Sleep disorders and mortality:a prospective study in the Canadian longitudinal study on aging [J ] . Sleep Med , 2024 , 114 : 128 - 136 .
ROSENBERG R P , BENCA R , DOGHRAMJI P , et al . A 2023 update on managing insomnia in primary care:insights from an expert consensus group [J ] . Prim Care Companion CNS Disord , 2023 , 25 ( 1 ): 22nr03385 .
张洪雄 , 高太祥 , 赵峰 , 等 . 药效学结合网络药理学研究酸枣仁汤对不同疾病模型的干预作用及其作用机制 [J ] . 世界科学技术-中医药现代化 , 2023 , 25 ( 7 ): 2465 - 2478 .
FAN K , YANG J J , GONG W Y , et al . NLRP3 inflammasome activation mediates sleep deprivation-induced pyroptosis in mice [J ] . Peer J , 2021 , 9 : e11609 .
龙盼 , 胡晓霞 , 胡琦兰 , 等 . 天麻素对氯苯丙氨酸(PCPA)致失眠小鼠的镇静催眠作用研究 [J ] . 中药药理与临床 , 2021 , 37 ( 5 ): 33 - 38 .
YAO R Y , HEINRICH M , WECKERLE C S . The genus Lycium as food and medicine:a botanical,ethnobotanical and historical review [J ] . J Ethnopharmacol , 2018 , 212 : 50 - 66 .
MA L J , HUO P C , SUN M R , et al . Research progress on chemical constituents and pharmacological activities of Lycium ruthenicum [J ] . Chin Tradit Herb Drugs , 2020 , 51 : 5884 - 5893 .
LU L , MI J , JIN B , et al . Inhibitory effects of the anthocyanins from Lycium ruthenicum Murray on angiotensin-Ⅰ-converting enzyme: in vitro and molecular docking studies [J ] . J Sci Food Agric , 2023 , 103 ( 14 ): 7164 - 7175 .
杨冬彦 . 黑果枸杞速溶粉的制备及其品质评价 [D ] . 北京 : 中国科学院大学(中国科学院过程工程研究所) , 2018 .
ALTENHOFEN S , BONAN C D . Zebrafish as a tool in the study of sleep and memory-related disorders [J ] . Curr Neuropharmacol , 2022 , 20 ( 3 ): 540 - 549 .
RU J L , LI P , WANG J N , et al . TCMSP:a database of systems pharmacology for drug discovery from herbal medicines [J ] . J Cheminform , 2014 , 6 : 13 .
徐琼 , 张恒 , 王辉 . 基于EGFR介导的信号通路探讨中药活性成分抗肿瘤研究进展 [J ] . 中国实验方剂学杂志 , 2023 , 29 ( 6 ): 246 - 253 .
WANG J H , CUI S Z , ZHANG X L , et al . High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer [J ] . PLoS One , 2013 , 8 ( 4 ): e62876 .
刘佳敏 , 王雅乐 , 黄海 , 等 . 基于转录组学探讨黑逍遥散调控PI3K/Akt通路改善肝郁型失眠大鼠学习记忆能力的作用机制 [J ] . 中国实验方剂学杂志 , 2025 , 31 ( 16 ): 114 - 125 .
IRWIN M R , OPP M R . Sleep health:reciprocal regulation of sleep and innate immunity [J ] . Neuropsychopharmacology , 2017 , 42 ( 1 ): 129 - 155 .
YANG D W , SUN X L , WANG H , et al . TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1β + macrophages [J ] . Gastroenterology , 2025 , 168 ( 6 ): 1153 - 1169 .
ZHENG Y D , ZHANG L Y , BONFILI L , et al . Probiotics supplementation attenuates inflammation and oxidative stress induced by chronic sleep restriction [J ] . Nutrients , 2023 , 15 ( 6 ): 1518 .
WANG W F , WANG Y C , GUO Q T , et al . Valerian essential oil for treating insomnia via the serotonergic synapse pathway [J ] . Front Nutr , 2022 , 9 : 927434 .
0
浏览量
11
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621